Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-11-19

FDA Approved: XYOSTED — Supplemental Application (Antares Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental labeling application for XYOSTED (testosterone enanthate) by Antares Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XYOSTED (Testosterone enanthate)

Snippet

SUPPL AP for XYOSTED (TESTOSTERONE ENANTHATE)